Fabulous news for people with heart problems. But what if you’re one of the millions of people suffering from a chronic eye disease like glaucoma.
This is the next big un-met societal need now being tackled by DSM via Jens Thies and his team. If successful, their polymeric implant could eventually eliminate the need for the daily application of eye drops for millions of glaucoma sufferers in Europe alone. But to eliminate that particular headache for patients, the team at DSM had to deal with a few of their own first.
“Our big roadblock was that biomaterial resorbs six times slower in the eye than in, say, the heart,” Jens says. “We had to find a way around this new problem, because we couldn’t leave empty implants in the eye for that long.” The question was, how?